- Home
- LEGN vs CWAN Comparison
LEGN vs CWAN Comparison
Compare LEGN & CWAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEGN
- CWAN
- Stock Information
- Founded
- LEGN 2014
- CWAN 2004
- Country
- LEGN United States
- CWAN United States
- Employees
- LEGN N/A
- CWAN N/A
- Industry
- LEGN Biotechnology: Pharmaceutical Preparations
- CWAN Computer Software: Prepackaged Software
- Sector
- LEGN Health Care
- CWAN Technology
- Exchange
- LEGN Nasdaq
- CWAN Nasdaq
- Market Cap
- LEGN 7.0B
- CWAN 7.3B
- IPO Year
- LEGN 2020
- CWAN 2021
- Fundamental
- Price
- LEGN $27.69
- CWAN $23.95
- Analyst Decision
- LEGN Strong Buy
- CWAN Buy
- Analyst Count
- LEGN 13
- CWAN 9
- Target Price
- LEGN $75.67
- CWAN $32.44
- AVG Volume (30 Days)
- LEGN 1.5M
- CWAN 3.5M
- Earning Date
- LEGN 05-13-2025
- CWAN 04-30-2025
- Dividend Yield
- LEGN N/A
- CWAN N/A
- EPS Growth
- LEGN N/A
- CWAN N/A
- EPS
- LEGN N/A
- CWAN 1.71
- Revenue
- LEGN $728,303,000.00
- CWAN $475,948,000.00
- Revenue This Year
- LEGN $65.96
- CWAN $63.47
- Revenue Next Year
- LEGN $52.55
- CWAN $28.99
- P/E Ratio
- LEGN N/A
- CWAN $13.94
- Revenue Growth
- LEGN 112.46
- CWAN 23.21
- 52 Week Low
- LEGN $29.27
- CWAN $17.42
- 52 Week High
- LEGN $60.87
- CWAN $35.71
- Technical
- Relative Strength Index (RSI)
- LEGN 29.04
- CWAN 51.59
- Support Level
- LEGN $30.25
- CWAN $23.91
- Resistance Level
- LEGN $33.30
- CWAN $24.63
- Average True Range (ATR)
- LEGN 1.78
- CWAN 0.64
- MACD
- LEGN -0.53
- CWAN 0.31
- Stochastic Oscillator
- LEGN 3.10
- CWAN 69.03
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
About CWAN Clearwater Analytics Holdings Inc.
Clearwater Analytics Holdings Inc provides a SaaS solution for automated investment data aggregation, reconciliation, accounting and reporting services to insurers, investment managers, corporations, institutional investors and government entities. It earns revenue from providing access to its SaaS platform to customers, services that support the implementation on the SaaS platform, selling perpetual and term-based software licenses and providing maintenance and support and professional services under contracts with customers. The majority of the revenue is earned in the United States.